MARKET

CNMD

CNMD

CONMED
NYSE

Real-time Quotes | Nasdaq Last Sale

136.99
+0.74
+0.54%
After Hours: 136.99 0 0.00% 16:00 06/11 EDT
OPEN
136.43
PREV CLOSE
136.25
HIGH
137.25
LOW
136.30
VOLUME
105.54K
TURNOVER
--
52 WEEK HIGH
146.95
52 WEEK LOW
65.74
MARKET CAP
3.99B
P/E (TTM)
379.26
1D
5D
1M
3M
1Y
5Y
Insider Selling in Conmed Corp (CNMD) Shares Continues
MT Newswires · 6d ago
Align Technology (ALGN) Launches New Features in iTero Family
Align Technology's (ALGN) iTero Workflow 2.0 software and iTero Element 5D Imaging system auto-upload functionality to drive innovation in digital orthodontics and restorative dentistry.
Zacks · 6d ago
Zimmer Biomet (ZBH) Witnesses Post-Pandemic Business Revival
Zimmer Biomet's (ZBH) spin-off decision of the non-core dental and spine business is expected to prove strategic.
Zacks · 6d ago
Insider Trends: Conmed Corp Insider Extends 90-Day Selling Trend
MT Newswires · 06/04 16:23
Henry Schein (HSIC) Clinches HHS Deal for COVID-19 Supplies
Zacks.com · 06/01 20:03
Medtronic (MDT) Diabetes Arm Secures Two Approvals in Europe
Zacks.com · 06/01 14:02
Why Is Conmed (CNMD) Down 3.9% Since Last Earnings Report?
Zacks.com · 05/28 15:31
Barclays sees "renaissance" in medical device industry
The medtech industry could be in the early stages "of another multi-year period out outperformance," according to a new analysis from Barclays.The firm has outlined 8 reasons why it is
Seekingalpha · 05/25 18:07
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CNMD. Analyze the recent business situations of CONMED through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CNMD stock price target is 157.75 with a high estimate of 175.00 and a low estimate of 141.00.
EPS
Institutional Holdings
Institutions: 350
Institutional Holdings: 34.14M
% Owned: 117.35%
Shares Outstanding: 29.09M
TypeInstitutionsShares
Increased
82
2.28M
New
21
433.76K
Decreased
96
1.59M
Sold Out
30
555.36K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.06%
Key Executives
Chairman/President/Chief Executive Officer/Director
Curt Hartman
Chief Financial Officer/Executive Vice President/IR Contact Officer
Todd Garner
Corporate Executive
Patrick Beyer
Executive Vice President/General Counsel/Secretary
Daniel Jonas
Executive Vice President/Director of Human Resources/Secretary
Heather Cohen
Executive Vice President
Wilfredo Ruiz-Caban
Executive Vice President
Peter Shagory
Vice President/General Manager
John Kennedy
Vice President/General Manager
Stanley Peters
Vice President/Controller
Terence Berge
Vice President/Treasurer
Johonna Pelletier
General Counsel/Assistant Secretary
Sarah Oliker
Lead Director/Independent Director
Martha Aronson
Director
Mark Tryniski
General Counsel/Assistant Secretary
SARAH OLIKER
Independent Director
David Bronson
Independent Director
Brian Concannon
Independent Director
Laverne Council
Independent Director
Charles Farkas
Independent Director
Jerome Lande
Independent Director
Barbara Schwarzentraub
Independent Director
John Workman
Declaration Date
Dividend Per Share
Ex-Div Date
05/19/2021
Dividend USD 0.2
06/14/2021
02/23/2021
Dividend USD 0.2
03/12/2021
11/13/2020
Dividend USD 0.2
12/14/2020
08/13/2020
Dividend USD 0.2
09/14/2020
05/21/2020
Dividend USD 0.2
06/12/2020
02/25/2020
Dividend USD 0.2
03/13/2020
11/21/2019
Dividend USD 0.2
12/12/2019
08/01/2019
Dividend USD 0.2
09/12/2019
05/22/2019
Dividend USD 0.2
06/13/2019
02/26/2019
Dividend USD 0.2
03/14/2019
11/08/2018
Dividend USD 0.2
12/13/2018
08/14/2018
Dividend USD 0.2
09/13/2018
05/24/2018
Dividend USD 0.2
06/14/2018
02/28/2018
Dividend USD 0.2
03/14/2018
11/27/2017
Dividend USD 0.2
12/14/2017
08/29/2017
Dividend USD 0.2
09/14/2017
05/24/2017
Dividend USD 0.2
06/13/2017
02/28/2017
Dividend USD 0.2
03/13/2017
11/21/2016
Dividend USD 0.2
12/13/2016
08/25/2016
Dividend USD 0.2
09/13/2016
  • All
  • Financials
  • Insiders
More
About CNMD
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company's product lines consist of orthopedic surgery and general surgery.

Webull offers kinds of Conmed Corp stock information, including NYSE:CNMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CNMD stock methods without spending real money on the virtual paper trading platform.